SOPHROSYNE CAPITAL LLC Information

156 EAST 36TH STREET, NEW YORK, New York, 10016, (212) 444-2500

Report Date: 06/30/2014

Position Statistics

Total Positions 93
New Positions 14
Increased Positions 30
Decreased Positions 53
Positions with Activity 83
Sold Out Positions 29
Total Mkt Value (in $ millions) 93

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials 3.03%
Capital Goods 5.88%
Conglomerates 0%
Consumer Cyclical 0.09%
Consumer/Non-Cyclical 2.2%
Energy 0.41%
Financial 6.51%
Healthcare 43.26%
Services 4.98%
Technology 23.69%
Transportation 0.24%
Utilities 2.43%

29 Sold Out Positions as of 06/30/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
8X8 INC NEW COM -269 Sold Out 0
ACELRX PHARMACEUTICALS INC COM -1,367 Sold Out 0
ACORN ENERGY INC COM -483 Sold Out 0
ASTERIAS BIOTHERAPEUTICS INC COM SER A -36 Sold Out 0
CUTERA INC COM -1,411 Sold Out 0
DURATA THERAPEUTICS INC COM -1,338 Sold Out 0
EDWARDS LIFESCIENCES CORP COM -715 Sold Out 0
FIVE PRIME THERAPEUTICS INC COM -262 Sold Out 0
GERON CORP COM -282 Sold Out 0
HANGER INC COM NEW -538 Sold Out 0
INSPIREMD INC COM NEW -370 Sold Out 0
LINDSAY CORP COM -127 Sold Out 0
NATURAL GAS SERVICES GROUP COM -171 Sold Out 0
NEKTAR THERAPEUTICS COM -727 Sold Out 0
NET 1 UEPS TECHNOLOGIES INC COM NEW -4,597 Sold Out 0
OCULUS INNOVATIVE SCIENCES INC COM NEW -326 Sold Out 0
OMEGA PROTEIN CORP COM -46 Sold Out 0
PHARMATHENE INC COM -324 Sold Out 0
PICO HLDGS INC COM NEW -251 Sold Out 0
QUALYS INC COM -286 Sold Out 0